You can buy or sell NeoGenomics and other stocks, options, ETFs, and crypto commission-free!
NeoGenomics, Inc. Common Stock, also called NeoGenomics, is a clinical laboratory, which specializes in cancer genetics diagnostic testing and pharma services. Read More It operates through the following two segments: Clinical and Pharma Services. The Clinical Services segment offers clinical cancer testing services to community-based pathologists. The Pharma Services segments supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. The Clinical Services Segment provides various clinical testing services to community-based pathology practices, hospital pathology labs and academic centers with reimbursement from various payers including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment: provides comprehensive testing services in supports pharmaceutical clients' oncology programs from discovery to commercialization. Its services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology and molecular genetic testing. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
Fort Myers, Florida
52 Week High
52 Week Low
Expected Feb 18, Pre-Market